Milestone Scientific (MLSS) Competitors

$0.34 -0.01 (-4.25%)

Closing price 04:00 PM Eastern

Extended Trading

$0.34 +0.01 (+2.24%)

As of 07:59 PM Eastern

MLSS vs. SPAI, LAKE, NRXS, PYPD, and OM

Should you buy Milestone Scientific stock or one of its competitors? MarketBeat compares Milestone Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Milestone Scientific include Safe Pro Group (SPAI), Lakeland Industries (LAKE), NeurAxis (NRXS), PolyPid (PYPD), and Outset Medical (OM). These companies are all part of the "medical equipment" industry.

How does Milestone Scientific compare to Safe Pro Group?

Milestone Scientific (NYSE:MLSS) and Safe Pro Group (NASDAQ:SPAI) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

Milestone Scientific has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market. Comparatively, Safe Pro Group has a beta of 3, suggesting that its stock price is 200% more volatile than the broader market.

Milestone Scientific has higher revenue and earnings than Safe Pro Group. Milestone Scientific is trading at a lower price-to-earnings ratio than Safe Pro Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.97M	3.01	-$6.93M	-$0.06	N/A
Safe Pro Group	$610K	151.02	-$14.32M	-$0.84	N/A

Milestone Scientific has a net margin of -52.01% compared to Safe Pro Group's net margin of -2,359.64%. Milestone Scientific's return on equity of -60.26% beat Safe Pro Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Safe Pro Group	-2,359.64%	-182.66%	-158.99%

5.8% of Milestone Scientific shares are owned by institutional investors. 12.5% of Milestone Scientific shares are owned by insiders. Comparatively, 54.8% of Safe Pro Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Milestone Scientific presently has a consensus target price of $1.00, indicating a potential upside of 198.06%. Safe Pro Group has a consensus target price of $10.00, indicating a potential upside of 126.76%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than Safe Pro Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Safe Pro Group	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.60

In the previous week, Safe Pro Group had 5 more articles in the media than Milestone Scientific. MarketBeat recorded 7 mentions for Safe Pro Group and 2 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.00 beat Safe Pro Group's score of -0.26 indicating that Milestone Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Safe Pro Group	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Milestone Scientific beats Safe Pro Group on 11 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to Lakeland Industries?

Milestone Scientific (NYSE:MLSS) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends.

Milestone Scientific has a beta of 0.97, suggesting that its share price is 3% less volatile than the broader market. Comparatively, Lakeland Industries has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market.

Milestone Scientific has higher earnings, but lower revenue than Lakeland Industries. Milestone Scientific is trading at a lower price-to-earnings ratio than Lakeland Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.97M	3.01	-$6.93M	-$0.06	N/A
Lakeland Industries	$192.65M	0.54	-$25.31M	-$2.58	N/A

Lakeland Industries has a net margin of -13.14% compared to Milestone Scientific's net margin of -52.01%. Lakeland Industries' return on equity of -9.57% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Lakeland Industries	-13.14%	-9.57%	-6.06%

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 71.7% of Lakeland Industries shares are owned by institutional investors. 12.5% of Milestone Scientific shares are owned by company insiders. Comparatively, 3.4% of Lakeland Industries shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Milestone Scientific presently has a consensus target price of $1.00, suggesting a potential upside of 198.06%. Lakeland Industries has a consensus target price of $15.20, suggesting a potential upside of 44.90%. Given Milestone Scientific's stronger consensus rating and higher probable upside, equities research analysts plainly believe Milestone Scientific is more favorable than Lakeland Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Lakeland Industries	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Lakeland Industries had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for Lakeland Industries and 2 mentions for Milestone Scientific. Lakeland Industries' average media sentiment score of 0.38 beat Milestone Scientific's score of 0.00 indicating that Lakeland Industries is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lakeland Industries	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Lakeland Industries beats Milestone Scientific on 10 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to NeurAxis?

NeurAxis (NASDAQ:NRXS) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

NeurAxis currently has a consensus target price of $13.00, suggesting a potential upside of 55.69%. Milestone Scientific has a consensus target price of $1.00, suggesting a potential upside of 198.06%. Given Milestone Scientific's higher possible upside, analysts plainly believe Milestone Scientific is more favorable than NeurAxis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

NeurAxis has a beta of 1.5, suggesting that its stock price is 50% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market.

Milestone Scientific has a net margin of -52.01% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeurAxis	-492.76%	N/A	-641.25%
Milestone Scientific	-52.01%	-60.26%	-40.23%

11.8% of NeurAxis shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 21.1% of NeurAxis shares are held by insiders. Comparatively, 12.5% of Milestone Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Milestone Scientific has higher revenue and earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeurAxis	$4.28M	22.44	-$14.63M	-$0.81	N/A
Milestone Scientific	$8.97M	3.01	-$6.93M	-$0.06	N/A

In the previous week, NeurAxis had 4 more articles in the media than Milestone Scientific. MarketBeat recorded 6 mentions for NeurAxis and 2 mentions for Milestone Scientific. NeurAxis' average media sentiment score of 0.53 beat Milestone Scientific's score of 0.00 indicating that NeurAxis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeurAxis	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

NeurAxis beats Milestone Scientific on 8 of the 14 factors compared between the two stocks.

How does Milestone Scientific compare to PolyPid?

Milestone Scientific (NYSE:MLSS) and PolyPid (NASDAQ:PYPD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation and institutional ownership.

In the previous week, PolyPid had 10 more articles in the media than Milestone Scientific. MarketBeat recorded 12 mentions for PolyPid and 2 mentions for Milestone Scientific. PolyPid's average media sentiment score of 0.52 beat Milestone Scientific's score of 0.00 indicating that PolyPid is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PolyPid	1 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Milestone Scientific has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market. Comparatively, PolyPid has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market.

PolyPid has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat PolyPid's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
PolyPid	N/A	-215.51%	-116.18%

Milestone Scientific presently has a consensus target price of $1.00, suggesting a potential upside of 198.06%. PolyPid has a consensus target price of $12.25, suggesting a potential upside of 179.68%. Given Milestone Scientific's stronger consensus rating and higher probable upside, research analysts clearly believe Milestone Scientific is more favorable than PolyPid.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
PolyPid	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 26.5% of PolyPid shares are owned by institutional investors. 12.5% of Milestone Scientific shares are owned by insiders. Comparatively, 24.7% of PolyPid shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Milestone Scientific has higher revenue and earnings than PolyPid. Milestone Scientific is trading at a lower price-to-earnings ratio than PolyPid, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.97M	3.01	-$6.93M	-$0.06	N/A
PolyPid	N/A	N/A	-$34.17M	-$1.91	N/A

Summary

PolyPid beats Milestone Scientific on 8 of the 15 factors compared between the two stocks.

How does Milestone Scientific compare to Outset Medical?

Milestone Scientific (NYSE:MLSS) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation and institutional ownership.

In the previous week, Outset Medical had 6 more articles in the media than Milestone Scientific. MarketBeat recorded 8 mentions for Outset Medical and 2 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.00 beat Outset Medical's score of -0.27 indicating that Milestone Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Outset Medical	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Milestone Scientific has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.92, suggesting that its stock price is 92% more volatile than the broader market.

Milestone Scientific has a net margin of -52.01% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Outset Medical	-63.65%	-56.13%	-27.45%

Milestone Scientific presently has a consensus target price of $1.00, suggesting a potential upside of 198.06%. Outset Medical has a consensus target price of $10.00, suggesting a potential upside of 162.47%. Given Milestone Scientific's stronger consensus rating and higher probable upside, research analysts clearly believe Milestone Scientific is more favorable than Outset Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

5.8% of Milestone Scientific shares are owned by institutional investors. 12.5% of Milestone Scientific shares are owned by insiders. Comparatively, 2.5% of Outset Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Milestone Scientific has higher earnings, but lower revenue than Outset Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.97M	3.01	-$6.93M	-$0.06	N/A
Outset Medical	$119.48M	0.59	-$81.65M	-$4.16	N/A

Summary

Milestone Scientific beats Outset Medical on 9 of the 17 factors compared between the two stocks.

Get Milestone Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MLSS vs. The Competition

Export

Metric	Milestone Scientific	Surgical appliances & supplies Industry	Medical Sector	NYSE Exchange
Market Cap	$26.99M	$24.11M	$6.34B	$22.91B
Dividend Yield	N/A	N/A	2.80%	4.09%
P/E Ratio	-4.79	15.89	17.79	27.68
Price / Sales	3.01	1.35	549.57	24.98
Price / Cash	N/A	12.80	43.26	25.31
Price / Book	3.05	1.40	9.93	4.67
Net Income	-$6.93M	-$3.92M	$3.55B	$1.06B
7 Day Performance	-28.46%	-10.66%	-0.33%	-0.76%
1 Month Performance	14.90%	10.20%	1.34%	1.73%
1 Year Performance	-62.31%	-31.79%	41.10%	25.04%

Milestone Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MLSS Milestone Scientific	1.3802 of 5 stars	$0.34 -4.3%	$1.00 +198.1%	-61.5%	$26.99M	$8.97M	N/A	30	News Coverage Gap Up
SPAI Safe Pro Group	2.6934 of 5 stars	$4.50 +2.5%	$10.00 +122.2%	+33.2%	$94M	$610K	N/A	11	Upcoming Earnings
LAKE Lakeland Industries	3.4993 of 5 stars	$9.50 -6.6%	$15.20 +60.0%	-42.5%	$93.44M	$192.65M	N/A	2,600
NRXS NeurAxis	3.0758 of 5 stars	$8.08 +8.5%	$13.00 +60.9%	+243.9%	$92.96M	$3.57M	N/A	19
PYPD PolyPid	3.3547 of 5 stars	$4.44 -1.3%	$12.25 +175.9%	+55.7%	$84.73M	N/A	N/A	80	News Coverage Earnings Report Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MLSS) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Milestone Scientific (MLSS) Competitors

MLSS vs. SPAI, LAKE, NRXS, PYPD, and OM

How does Milestone Scientific compare to Safe Pro Group?

Summary

How does Milestone Scientific compare to Lakeland Industries?

Summary

How does Milestone Scientific compare to NeurAxis?

Summary

How does Milestone Scientific compare to PolyPid?

Summary

How does Milestone Scientific compare to Outset Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Milestone Scientific (MLSS) Competitors

MLSS vs. SPAI, LAKE, NRXS, PYPD, and OM

How does Milestone Scientific compare to Safe Pro Group?

Which has more risk and volatility, MLSS or SPAI?

Which has stronger valuation & earnings, MLSS or SPAI?

Is MLSS or SPAI more profitable?

Do institutionals & insiders have more ownership in MLSS or SPAI?

Do analysts recommend MLSS or SPAI?

Does the media prefer MLSS or SPAI?

Summary

How does Milestone Scientific compare to Lakeland Industries?

Which has more volatility & risk, MLSS or LAKE?

Which has higher earnings & valuation, MLSS or LAKE?

Is MLSS or LAKE more profitable?

Do insiders and institutionals have more ownership in MLSS or LAKE?

Do analysts recommend MLSS or LAKE?

Does the media favor MLSS or LAKE?

Summary

How does Milestone Scientific compare to NeurAxis?

Do analysts rate NRXS or MLSS?

Which has more risk and volatility, NRXS or MLSS?

Is NRXS or MLSS more profitable?

Do institutionals and insiders have more ownership in NRXS or MLSS?

Which has better earnings & valuation, NRXS or MLSS?

Does the media refer more to NRXS or MLSS?

Summary

How does Milestone Scientific compare to PolyPid?

Does the media prefer MLSS or PYPD?

Which has more volatility and risk, MLSS or PYPD?

Is MLSS or PYPD more profitable?

Do analysts rate MLSS or PYPD?

Do institutionals & insiders hold more shares of MLSS or PYPD?

Which has higher valuation & earnings, MLSS or PYPD?

Summary

How does Milestone Scientific compare to Outset Medical?

Does the media prefer MLSS or OM?

Which has more volatility and risk, MLSS or OM?

Is MLSS or OM more profitable?

Do analysts rate MLSS or OM?

Do institutionals & insiders hold more shares of MLSS or OM?

Which has higher valuation & earnings, MLSS or OM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools